AN ANSWER TO HUMAN DISEASES
MAY LIE IN THE SMALLEST KNOWN
REALMS OF LIFE.
That's the promise of structural bioinformatics, an exciting
new field involving the simulation and imaging of human diseases at the level of single molecules or molecular assemblies. By studying the actions and interactions within life's subcellular machinery that provides structure, control, signaling and motility, we're finding better drug and treatment options. We're also learning how to diagnose diseases earlier. Thereby, our research builds bridges between the smallest size bio-molecules and clinical practice.
In 2007, Biomachina founder Willy Wriggers moved to New York City to pursue independent research interests. An active research group continues today in Houston under the academic leadership of Stefan Birmanns.